The 1,220-basis-point operating margin expansion between Q3 2024 and Q3 2026, achieved while COGS remained roughly flat near $4.9B per quarter, appears consistent with the re-franchising and pricing regime shift flagged in the prior income statement work rather than a cyclical cost deferral. Net margin of 30.0% in Q3 2026 is exceptional for the sector, but investors should note it includes roughly $2.3B of equity-method income from bottlers and Monster that never passes through revenue, making operating margin the more reliable gauge of core earning power.

With net PPE near $9.5B and asset turnover stuck at 0.11-0.12 for ten consecutive quarters, KO's invested-capital denominator understates the economic asset intensity of the system, since bottling and distribution assets sit with third parties. The 4.9% ROIC versus 10.3% ROE spread suggests reported returns on equity are partly a function of the remaining $41.6B debt load rather than superior asset productivity, and versus PEP's 50.3% ROE — itself leverage-amplified — the comparison warrants adjusting for each company's capital structure before concluding on relative quality.

Total debt declined 16% from $49.4B to $41.6B over roughly five quarters, but the more consequential shift is that operating income scaled from $2.5B to $4.5B per the prior analysis, which mechanically halved the leverage ratios. Coverage at 14.65x with $13.5B of cash on hand suggests refinancing risk is modest even in a higher-rate backdrop, though the 79% dividend absorption of FCF identified in the cash flow review means incremental debt capacity for acquisitions is constrained relative to what headline coverage alone implies.

The exceptionally long DPO of 273-294 days indicates KO collects from bottlers far faster than it pays its own suppliers, effectively financing operations on working capital — a competitive position that the prior cash flow analysis noted creates violent quarterly swings (from -$8.5B to +$2.3B in reported working capital). Q3 2026 DPO and CCC were not disclosed in the dataset, so the durability of this cycle cannot be confirmed this quarter, but the multi-quarter trend suggests the efficiency gains are structural to the concentrate model rather than one-off timing effects.

The 33% P/E premium to PEP and 44% EV/EBITDA premium to PEP appear to price KO's pure-play beverage focus and margin trajectory rather than superior growth, especially given that forward multiples compress only modestly relative to trailing figures. The 2.2% dividend yield versus PEP's 4.2% further suggests KO is being valued as a quality compounder rather than an income name, which leaves the multiple vulnerable if the revenue deceleration from 12.1% to 7.4% — flagged in the income statement review — proves to be the pricing engine exhausting itself.